PMID: 6109147Dec 20, 1980Paper

The Northwick Park electroconvulsive therapy trial

Lancet
E JohnstoneT J Crow

Abstract

70 patients with endogenous depression, defined by strict criteria, who fulfilled the Newcastle indications for electroconvulsive therapy (ECT) were randomly allocated either to a course of eight simulated ECTs or to a course of eight real ECTs. The improvement in terms of psychiatrists' ratings in the group of patients given real ECT was significantly greater (p < 0.01) than that in those given simulated ECT, but the difference between the two groups was small in relation to the considerable improvement of both groups over the 4-week treatment period. No differences were found between the two groups at one-month and six-month follow-up. The therapeutic benefits of electrically induced convulsions in depression were of lesser magnitude and were more transient than has sometimes been claimed. In the real-ECT group memory was impaired during treatment but memory tests revealed no difference between the groups at six-month follow-up.

References

Dec 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·J Lambourn, D Gill
Feb 1, 1976·The British Journal of Psychiatry : the Journal of Mental Science·R P SnaithM Hamilton
Oct 1, 1975·The Journal of Nervous and Mental Disease·R G Harper, A N Wiens
Dec 1, 1975·Archives of General Psychiatry·L R Squire, P M Chace
Feb 1, 1976·Archives of General Psychiatry·D E Sternberg, M E Jarvik
Jan 1, 1972·Archives of General Psychiatry·J P FeighnerR Munoz
Dec 1, 1967·The British Journal of Social and Clinical Psychology·M Hamilton
May 1, 1959·A.M.A. Archives of Neurology and Psychiatry·N Q BRILLR A RICHARDS
Sep 1, 1963·Archives of General Psychiatry·W E BUNNEY, D A HAMBURG
Apr 1, 1964·The American Journal of Psychiatry·M GREENBLATTH WECHSLER
Aug 1, 1965·The British Journal of Psychiatry : the Journal of Mental Science·M W CARNEYR F GARSIDE
Mar 1, 1962·The Journal of Mental Science·A A ROBIN, J A HARRIS

❮ Previous
Next ❯

Citations

Jul 12, 2001·Advances in Therapy·H Youssef, F Youssef
Apr 4, 1995·Journal of Affective Disorders·D O'LearyC Shawcross
Mar 1, 1986·Psychiatry Research·B Shapira, B Lerer
May 1, 1987·Psychiatry Research·D A McAllisterA Sattin
Mar 1, 1990·Psychiatry Research·J PrudicD P Devanand
Jan 1, 1983·Progress in Neuro-psychopharmacology & Biological Psychiatry·B Lerer, N Sitaram
Mar 5, 1994·Lancet
Feb 16, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K McPherson, A Britton
Nov 1, 1993·Psychological Medicine·G DunnD Hand
May 1, 1993·Psychological Medicine·F J LetemendiaD W Lywood
Feb 1, 1983·Psychological Medicine·A L Johnson
Aug 1, 1982·Psychological Medicine·M D Kopelman
Jul 19, 1984·The New England Journal of Medicine·R R Crowe
Oct 13, 2009·Journal of Psychiatric Practice·Nancy A Payne, Joan Prudic
Jul 11, 1981·British Medical Journal·S M Gore
Jul 18, 1981·British Medical Journal·S M Gore
Apr 2, 1983·British Medical Journal·J F Deakin
Jan 7, 1984·British Medical Journal·S BrandonS Wellstood-Eason
Nov 26, 1988·BMJ : British Medical Journal·A Linington, B Harris
Jul 22, 2006·Ethical Human Psychology and Psychiatry·Colin A Ross
Nov 22, 2011·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Ross A Dunne, Declan M McLoughlin
Jan 1, 1986·Annals of the New York Academy of Sciences·T J Crow, E C Johnstone
Jan 1, 1986·Annals of the New York Academy of Sciences·H A Sackeim
Jan 28, 1987·The New Zealand Medical Journal·L Shenkin
Jan 1, 1988·Journal of Psychopharmacology·E S Paykel
Dec 1, 1988·The Australian and New Zealand Journal of Psychiatry·J Durham
Jan 1, 1991·Journal of Psychopharmacology·K MalcolmM Peet
Dec 1, 1989·The Australian and New Zealand Journal of Psychiatry·J Durham
Sep 1, 1983·The Australian and New Zealand Journal of Psychiatry·L G Kiloh
Sep 1, 1995·The Australian and New Zealand Journal of Psychiatry·A Frukacz, P Mitchell
Mar 29, 2006·Violence Against Women·Bonnie Burstow
Jul 1, 1986·Journal of Clinical Psychology·D J Weeks

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.